ProFound AI® Risk
Revolutionizing Personalized Screening
Now available for 2D and 3D mammography
Learn More
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
POWERFUL CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions
Discover how our new partnership with Google Health will elevate the performance of our technology and expand access to millions of women worldwide.
Learn More
As seen on:
Upcoming Webinar
ProFound Insights, ProFound Impact
Leveraging ProFound AI to Enhance Patient Care at Solis Mammography
Wednesday, December 14, 2022 | 3:00 pm ET • 12:00 pm PT
Chirag Parghi, MD
Chief Medical Officer, Solis Mammography
Breast cancer has finally met its match
Recent News
November 28, 2022
iCAD and Google Health In Strategic Development and Commercialization Agreement
November 21, 2022
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
November 15, 2022
iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference
November 14, 2022
iCAD to Present at HLTH 2022 With Google
November 10, 2022
iCAD Reports Financial Results for Third Quarter Ended September 30, 2022
» View All News »
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.